Rayatpour, A.; Farhangi, S.; Verdaguer, E.; Olloquequi, J.; Ureña, J.; Auladell, C.; Javan, M.
The Cross Talk between Underlying Mechanisms of Multiple Sclerosis and Epilepsy May Provide New Insights for More Efficient Therapies. Pharmaceuticals 2021, 14, 1031.
https://doi.org/10.3390/ph14101031
AMA Style
Rayatpour A, Farhangi S, Verdaguer E, Olloquequi J, Ureña J, Auladell C, Javan M.
The Cross Talk between Underlying Mechanisms of Multiple Sclerosis and Epilepsy May Provide New Insights for More Efficient Therapies. Pharmaceuticals. 2021; 14(10):1031.
https://doi.org/10.3390/ph14101031
Chicago/Turabian Style
Rayatpour, Atefeh, Sahar Farhangi, Ester Verdaguer, Jordi Olloquequi, Jesus Ureña, Carme Auladell, and Mohammad Javan.
2021. "The Cross Talk between Underlying Mechanisms of Multiple Sclerosis and Epilepsy May Provide New Insights for More Efficient Therapies" Pharmaceuticals 14, no. 10: 1031.
https://doi.org/10.3390/ph14101031
APA Style
Rayatpour, A., Farhangi, S., Verdaguer, E., Olloquequi, J., Ureña, J., Auladell, C., & Javan, M.
(2021). The Cross Talk between Underlying Mechanisms of Multiple Sclerosis and Epilepsy May Provide New Insights for More Efficient Therapies. Pharmaceuticals, 14(10), 1031.
https://doi.org/10.3390/ph14101031